<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T20:04:54Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5445308" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:5445308</identifier><datestamp>2017-05-30</datestamp><setSpec>orphjrdis</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="letter">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Orphanet J Rare Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Orphanet J Rare Dis</journal-id>
      <journal-title-group>
        <journal-title>Orphanet Journal of Rare Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1750-1172</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC5445308</article-id>
      <article-id pub-id-type="pmcid">PMC5445308</article-id>
      <article-id pub-id-type="pmc-uid">5445308</article-id>
      <article-id pub-id-type="pmid">28545593</article-id>
      <article-id pub-id-type="publisher-id">654</article-id>
      <article-id pub-id-type="doi">10.1186/s13023-017-0654-9</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter to the Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>PIGO deficiency: palmoplantar keratoderma and novel mutations</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Morren</surname>
            <given-names>Marie-Anne</given-names>
          </name>
          <address>
            <email>marie-anne.morren@uzkuleuven.be</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1571-9707</contrib-id>
          <name>
            <surname>Jaeken</surname>
            <given-names>Jaak</given-names>
          </name>
          <address>
            <phone>+32 16 343834</phone>
            <email>jaak.jaeken@kuleuven.be</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff9">9</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Visser</surname>
            <given-names>Gepke</given-names>
          </name>
          <address>
            <email>gvisser4@umcutrecht.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salles</surname>
            <given-names>Isabelle</given-names>
          </name>
          <address>
            <email>i.salles@imperial.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Van Geet</surname>
            <given-names>Chris</given-names>
          </name>
          <address>
            <email>christel.vangeet@uzleuven.be</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <collab>NIHR BioResource</collab>
          <address>
            <email>sp605@cam.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Simeoni</surname>
            <given-names>Ilenia</given-names>
          </name>
          <address>
            <email>is250@cam.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff7">7</xref>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Turro</surname>
            <given-names>Ernest</given-names>
          </name>
          <address>
            <email>et341@cam.ac.uk</email>
          </address>
          <xref ref-type="aff" rid="Aff6">6</xref>
          <xref ref-type="aff" rid="Aff8">8</xref>
          <xref ref-type="aff" rid="Aff10">10</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Freson</surname>
            <given-names>Kathleen</given-names>
          </name>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution>Departments of Dermatology, </institution><institution>University of Leuven, </institution></institution-wrap>Leuven, Belgium </aff>
        <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution>Pediatrics, </institution><institution>University of Leuven, </institution></institution-wrap>Leuven, Belgium </aff>
        <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0620 3132</institution-id><institution-id institution-id-type="GRID">grid.417100.3</institution-id><institution>Department of Pediatrics, </institution><institution>Wilhelmina Childrenâs Hospital, </institution></institution-wrap>Utrecht, The Netherlands </aff>
        <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2113 8111</institution-id><institution-id institution-id-type="GRID">grid.7445.2</institution-id><institution>Centre for Hematology, </institution><institution>Imperial College, </institution></institution-wrap>London, UK </aff>
        <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0668 7884</institution-id><institution-id institution-id-type="GRID">grid.5596.f</institution-id><institution>Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, </institution><institution>University of Leuven, </institution></institution-wrap>Leuven, Belgium </aff>
        <aff id="Aff6"><label>6</label>NHS Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK </aff>
        <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000000121885934</institution-id><institution-id institution-id-type="GRID">grid.5335.0</institution-id><institution>Department of Haematology, </institution><institution>University of Cambridge, Cambridge Biomedical Campus, </institution></institution-wrap>Cambridge, UK </aff>
        <aff id="Aff8"><label>8</label>Medical Research Council Biostatistics Unit, Cambridge Institute of Public Health, Cambridge Biomedical Campus, Cambridge, UK </aff>
        <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0626 3338</institution-id><institution-id institution-id-type="GRID">grid.410569.f</institution-id><institution>Department of Pediatrics, Center for Metabolic Diseases, </institution><institution>University Hospital Gasthuisberg, </institution></institution-wrap>Herestraat 49, BE 3000 Leuven, Belgium </aff>
        <aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0383 8386</institution-id><institution-id institution-id-type="GRID">grid.24029.3d</institution-id><institution>NIHR BioResource - Rare Diseases, </institution><institution>Cambridge University Hospitals, Cambridge Biomedical Campus, </institution></institution-wrap>Cambridge, UK </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>25</day>
        <month>5</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>25</day>
        <month>5</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <volume>12</volume>
      <elocation-id>101</elocation-id>
      <history>
        <date date-type="received">
          <day>31</day>
          <month>12</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Â© The Author(s). 2017</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Several genetic defects have been identified in the glycosylphosphatidylinositol (GPI) anchor synthesis, including mutations in <italic>PIGO</italic> encoding phosphatidylinositol glycan anchor biosynthesis class O protein. These defects constitute a subgroup of the congenital disorders of glycosylation (CDG). Seven patients from five families have been reported carrying variants in <italic>PIGO</italic> that cause an autosomal recessive syndrome characterised by dysmorphism, psychomotor disability, epilepsy and hyperphosphatasemia.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>Whole exome sequencing was performed in a boy with dysmorphism, psychomotor disability, epilepsy, palmoplantar keratoderma, hyperphosphatasemia and platelet dysfunction without a clinical bleeding phenotype.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Two novel variants in <italic>PIGO</italic> were detected. The missense variant encoding p. His871Pro was inherited from the boyâs father while the frameshift variant encoding p. Arg604ProfsTer40 was maternally inherited.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>A boy with two novel <italic>PIGO</italic> variants is reported. The skin phenotype and platelet dysfunction in this patient have not been described in previously reported patients with PIGO deficiency but it is of course uncertain whether these are caused by this disorder. The literature on PIGO deficiency is reviewed.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s13023-017-0654-9) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>CDG</kwd>
        <kwd>Congenital disorder(s) of glycosylation</kwd>
        <kwd>Glycosylphosphatidylinositol</kwd>
        <kwd>GPI</kwd>
        <kwd>Hyperkeratosis</kwd>
        <kwd>Hyperphosphatasemia</kwd>
        <kwd>PIGO-CDG</kwd>
        <kwd>Platelet dysfunction</kwd>
      </kwd-group>
      <funding-group>
        <award-group>
          <funding-source>
            <institution>FWO-Vlaanderen, Belgium</institution>
          </funding-source>
          <award-id>G.0B17.13N</award-id>
          <principal-award-recipient>
            <name>
              <surname>Freson</surname>
              <given-names>Kathleen</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>BOF KU Leuven, Belgium</institution>
          </funding-source>
          <award-id>OT/14/098</award-id>
          <principal-award-recipient>
            <name>
              <surname>Freson</surname>
              <given-names>Kathleen</given-names>
            </name>
          </principal-award-recipient>
        </award-group>
        <award-group>
          <funding-source>
            <institution>NIHR UK</institution>
          </funding-source>
          <award-id>RG65966</award-id>
        </award-group>
      </funding-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>Â© The Author(s) 2017</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>GPI anchors are a group of glycolipids with a glycan core, a phosphoethanolamine linker and a phospholipid tail. At least 150 human cell-surface proteins are posttranslationally modified by GPI anchors at the carboxyl-terminus. These proteins are anchored to the outer leaflet of the plasma membrane via the phosphatidylinositol moiety. These GPI-anchored proteins include adhesion molecules, complement regulatory proteins, hydrolytic enzymes, protease inhibitors and receptors. At least 26 genes are involved in the biosynthesis, protein-attachment and remodelling of mammalian GPI [<xref ref-type="bibr" rid="CR1">1</xref>]. Genetic defects have been reported in 12 of these genes [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. They belong to subgroup 3 in the current classification of congenital disorders of glycosylation (CDG) [<xref ref-type="bibr" rid="CR4">4</xref>]. One of them is a defect in phosphatidylinositol glycan anchor biosynthesis class O protein (PIGO). This enzyme, together with PIGF, catalyzes the attachment of ethanolamine phosphate to the third mannose of the three-mannosyl glycan core of GPI. Seven patients have been reported from five families with PIGO deficiency [<xref ref-type="bibr" rid="CR5">5</xref>â<xref ref-type="bibr" rid="CR8">8</xref>]. The present report is on a patient who expands the phenotypic spectrum of PIGO deficiency and carries novel mutations in the PIGO gene.</p>
    </sec>
    <sec id="Sec2">
      <title>Patient report</title>
      <p>The boy was born in 1994 from unrelated healthy parents from Afro-Caribbean ancestry after a 34Â weeks pregnancy. He has a healthy sister. The family history was negative for keratotic disorders. Pregnancy was complicated by polyhydramnion from the fourth month. Delivery was normal. Birth weight was 2870Â g, length unknown and head circumference 36.5Â cm. At birth, he showed oedema, especially of the distal ends of the extremities, as well as dysmorphism: broad nasal bridge, right preauricular tag, W-shaped upper lip, relatively large mouth, fusion of upper medial incisors, short neck, hypogenitalism and hypogonadism (testicles not palpable), and hypoplastic toenails. At 6 weeks, a deep infantile hemangioma was noted on the right upper thorax. At 4 months, he was operated for a right inguinal hernia. He had focal epilepsy at the age of 17Â months, which changed to multifocal epilepsy and was reasonably controlled with valproate. Both motor and cognitive development were severely disabled. He started to walk at 3.5Â years (abnormal gait with abduction of both feet), and said âmamaâ and âpapaâ at about 6Â years.</p>
      <p>On physical examination at 7Â years, height was 123Â cm (SDS 0.0), weight 25.5Â kg (SDS 0.6), head circumference 56Â cm (SDS 2.5). He smiled all the time. Moderate obesity, convergent strabism and general hyperlaxity were noted but no hypotonia. There was a residual hemangioma on the right upper thorax. Dysmorphism included malalignment of the upper medial incisors (no fusion of the permanent teeth), a broad nasal bridge, coarse ears, widely spaced nipples, mild camptodactyly of the fingers, and small hands and feet with short fingers and toes. There was a striking hyperkeratosis of the foot soles and hand palms.</p>
      <p>Physical examination at 11.5Â years showed a height of about 144Â cm (SDS â 0.7), weight 40Â kg (SDSâ+â0.2) and head circumference 57Â cm (SDSâ+â1.9). He was still incontinent for urine and faeces. The father mentioned progress in language understanding but speech was absent and he made himself understandable with gestures. He walked with his feet in 90 degrees abduction. There was a thickened palmar and plantar skin, more pronounced on pressure points, with a fine scaling extending over the dorsal side of hands and feet including the wrists and ankles. This thickened skin showed accentuation of the skin lines, particularly on the wrists. On the extensor side of elbows and knees the same thickened skin was seen (Figs.Â <xref rid="Fig1" ref-type="fig">1</xref> and <xref rid="Fig2" ref-type="fig">2</xref>). Vision and hearing were clinically normal. There was no hepatosplenomegaly. Cardiopulmonary examination was normal. The testes were small (walnut size). Tendon reflexes were brisk. He had a mild anal prolapse on pressure.<fig id="Fig1"><label>Fig. 1</label><caption><p>The patient at age 13Â years. Note facial dysmorphism, exorotation of the feet and keratoderma of the dorsum of the <italic>right hand</italic>
</p></caption><graphic xlink:href="13023_2017_654_Fig1_HTML" id="MO1"/></fig>
<fig id="Fig2"><label>Fig. 2</label><caption><p>Keratoderma of the hands, foot soles and knees of the patient at 13Â years</p></caption><graphic xlink:href="13023_2017_654_Fig2_HTML" id="MO2"/></fig>
</p>
      <p>Laboratory investigation showed persistently increased serum alkaline phosphatase (last control at 13Â years: 5131 U/L; normalâ&lt;â720) mainly due to increased bone isozyme. There was also a decreased serum apolipoprotein B (0.42Â g/L; normal range 0.66â1.33) and LDL-cholesterol (37Â mg/dL) with normal HDL cholesterol and triglycerides as well as a mild increase of serum amylase (121 U/L; normal range 28â100) and thyroid stimulating hormone (6.64 mIU/L; normal range 0.27â4.20) but with normal free T4 and thyroxin-binding globulin levels. Further routine blood and urine chemistry as well as metabolic screening were normal including serum calcium, phosphate, transaminases, creatine kinase, lactate dehydrogenase, factor XI, ceruloplasmin, cholinesterase, lipase, IgA, IgG, IgM and serum transferrin isoelectrofocusing.</p>
      <p>The patient had no obvious clinical bleeding problem and his Ivy bleeding time was normal as were all blood cell counts. Repeated platelet function testing showed decreased aggregation responses for ristocetin, ADP, epinephrine and Horm collagen (Fig.Â <xref rid="Fig3" ref-type="fig">3a</xref>). A similar multi - agonist platelet activation defect was detected using a high-throughput ELISA that records dose response activation of platelets where monoclonal antibodies against P-selectin (CD62P) or Î±IIbÎ²3 and GPIbÎ± were used to capture and detect platelet activation with ADP, U46619, TRAP and CRP [<xref ref-type="bibr" rid="CR9">9</xref>] (Fig.Â <xref rid="Fig3" ref-type="fig">3b</xref>). In contrast, ATP secretion from dense granules after stimulation with 2Â Î¼g/ml Horm collagen was normal (4.1 and 4.8Â Î¼M; normal range of 2â7Â Î¼M). As mentioned above, the patient is on valproate therapy that is known to have slight effects on the arachidonic pathway of platelets. However, the observed broad platelet activation defect of this patient is not compatible with a defect in the arachidonic pathway. It was not possible to withdraw the drug for further platelet testing.<fig id="Fig3"><label>Fig. 3</label><caption><p>Platelet function studies. <bold>a</bold> Platelet aggregation with Horm collagen (2Â Î¼g/ml), ADP (5Â Î¼M) and epinephrine (5Â Î¼g/ml) was reduced in the patient. <bold>b</bold> A high throughput ELISA was performed that records dose response activation of platelets with monoclonal antibodies against P-selectin (CD62P) or Î±IIbÎ²3 to detect platelet activation with ADP, U46619, TRAP and CRP at different concentrations</p></caption><graphic xlink:href="13023_2017_654_Fig3_HTML" id="MO3"/></fig>
</p>
      <p>Radiological examination of the skeleton showed a thin cortex, triangular distal toe phalanges, scoliosis, wedge-shaped anterior flattening of the vertebrae, and a fusion anomaly of the arcus posterior of D3. MRI of the brain at 6Â years showed enlarged lateral ventricles, a cavum septum pellucidum, a thin corpus callosum, and minimal white matter lesions at the level of the posterior horns.</p>
      <p>A skin biopsy at the elbow showed a âbasket wovenâ hyperorthokeratosis with papillomatosis. Electronmicroscopy revealed clear vesicles but this might have been a technical artefact.</p>
      <p>DNA from the patient was analysed by whole exome sequencing (WES) as part of the NIHR BRIDGE-Bleeding and Platelet Disorders study [<xref ref-type="bibr" rid="CR10">10</xref>] and compound heterozygous (and X-linked) rare variants were found in 8 genes that included two previously unreported variants in the <italic>PIGO</italic> gene for phosphatidylinositol glycan anchor biosynthesis class O protein. Details on gene selection from the WES data is described in the supplementary data (Additional file <xref rid="MOESM1" ref-type="media">1</xref>). Interestingly, recessive <italic>PIGO</italic> variants cause hyperphosphatasemia with mental retardation syndrome 2 (MIM 614749), as found in the patient. The missense variant c.2612Aâ&gt;âC (p.His871Pro) was absent from ExAC while the frameshift variant c.1810dupC (p.Arg604ProfsTer40) was present in ExAC at a minor allele frequency (MAF) of 0.0001 (0.0002 in non-Finnish Europeans). Sanger sequencing confirmed the variants in the child and the mother was the carrier of the variant encoding p.Arg604ProfsTer40 while DNA from the father showed he carried the variant encoding p.His871Pro. Different DNA variant scoring systems predict p.His871Pro as pathogenic with CADD score of 20, PolyPhen score of 0.836 (âpossibly damagingâ), SIFT score of 5.44 (âdeleteriousâ) and GERP score of 5.44.</p>
    </sec>
    <sec id="Sec3">
      <title>Discussion</title>
      <p>To date, only 7 patients from 5 families have been described with PIGO deficiency (TableÂ <xref rid="Tab1" ref-type="table">1</xref>) [<xref ref-type="bibr" rid="CR5">5</xref>â<xref ref-type="bibr" rid="CR8">8</xref>]. Interestingly, they all carry the combination of a high impact variant with a missense variant in <italic>PIGO</italic>. TableÂ <xref rid="Tab1" ref-type="table">1</xref> summarizes the clinical findings of the previously reported patients and our patient. All eight patients had a moderate or severe psychomotor disability as well as hyperphosphatasemia. The following symptoms were present in the majority of patients: epilepsy (6/8), facial dysmorphism (6/8), brachytelephalangy (5/8), nail hypoplasia (4/7), and anorectal abnormalities (5/6). A minority of patients showed various neurological, cardiac, urogenital and skeletal abnormalities. Novel features observed in our patient include palmoplantar keratoderma, extreme rotation of the feet, dental abnormalities and platelet dysfunction.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of clinical features and mutations in PIGO-deficient patients</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th>Krawitz et al. (pt A1)</th><th>Krawitz et al. (pt A2)</th><th>Krawitz et al. (pt B1)</th><th>Kuki et al.</th><th>Nakamura et al. (pt 1)</th><th>Nakamura et al. (pt 2)</th><th>Xue et al.</th><th>Present report</th></tr></thead><tbody><tr><td>Age</td><td>15Â years at publication</td><td>12Â years at publication</td><td>Died at 22Â months</td><td>9Â years at publication</td><td>19Â years at publication</td><td>Died at 1Â year</td><td>26Â months at publication</td><td>22Â years at present</td></tr><tr><td>Gender</td><td>Female</td><td>Female</td><td>Female</td><td>Male</td><td>Male</td><td>Female</td><td>Male</td><td>Male</td></tr><tr><td>Psychomotor disability</td><td>Severe</td><td>Moderate</td><td>Severe</td><td>Moderate</td><td>Severe</td><td>Severe</td><td>Moderate/severe</td><td>Moderate</td></tr><tr><td>Microcephaly</td><td>NA</td><td>NA</td><td>+</td><td>+</td><td>+</td><td>NA</td><td>Not at birth</td><td>-</td></tr><tr><td>Epilepsy</td><td>-</td><td>-</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Facial dysmorphism</td><td>Hypertelorism, wide-set eyes, long palpebral fissures, short nose, broad nasal bridge and tip, tented mouth</td><td>Hypertelorism, wide-set eyes, long palpebral fissures, short nose, broad nasal bridge and tip, tented mouth</td><td>Facial asymmetry, hypertelorism, wide-set eyes, long palpebral fissures, short nose, broad nasal bridge and tip, tented mouth, large ears with fleshy and uplifted earlobes</td><td>Coarse face, hypertelorism, blepharophimosis, short nose, broad nasal bridge, L cleft lip, low-set ears</td><td>High arched palate, tented mouth</td><td>-</td><td>-</td><td>Broad nasal bridge, relatively large mouth, fusion of upper medial milk incisors, W-shaped upper lip, coarse ears, R preauricular tag</td></tr><tr><td>Brachytelephalangy</td><td>+</td><td>+</td><td>+</td><td>+</td><td>-</td><td>-</td><td>-</td><td>+</td></tr><tr><td>Nail hypoplasia</td><td>Fingers and toes</td><td>Fingers and toes</td><td>Fingers and toes</td><td>NA</td><td>-</td><td>-</td><td>-</td><td>Toes</td></tr><tr><td>Anorectal abnormalities</td><td>Anal stenosis</td><td>Anal stenosis</td><td>Anal atresia with perineal fistula</td><td>Hirschsprung disease</td><td>NA</td><td>NA</td><td>-</td><td>Mild anal prolapse on pressure</td></tr><tr><td>Hyperphosphatasemia</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td><td>+</td></tr><tr><td>Other features</td><td>Growth retardation, broad halluces, vesicoureteral reflux</td><td>Broad halluces, atonic bladder</td><td>Growth retardation, L coronal synostosis, broad halluces, atrial septal defect, peripheral pulmonary synostosis, enlarged supratentorial ventricular system</td><td>Deafness, hypotonia, tetralogy of Fallot, brain hypomyelination</td><td>Chorea, hypotonia, abnormal auditory brain response, cerebral and cerebellar atrophy at 6Â years</td><td/><td>Brain diffusion-weighted magnetic resonance imaging: slightly high signal in globus pallidus and dorsal brain stem</td><td>Macrocephaly, convergent strabism, palmoplantar keratoderma, hemangioma R upper thorax, exorotation of the feet, hypotonia, hyperlaxity, camptodactyly of fingers, hypogonadism, enlarged lateral ventricles, thin corpus callosum, small white matter lesions</td></tr><tr><td>Mutations: cDNA/protein</td><td>c.2869Câ&gt;âT/p.Leu957Phe<break/>c.2361dupC/p.Thr788Hisfs*5</td><td>c.2869Câ&gt;âT/p.Leu957Phe<break/>c.2361dupC/p. Thr788Hisfs*5</td><td>c.2869Câ&gt;âT/p.Leu957Phe<break/>c.3069â+â5Gâ&gt;âA</td><td>c.355Câ&gt;âT/p.Arg119Trp<break/>c.23497_23498del/p.Ala834fs</td><td>c.389Câ&gt;âA/p.Thr130Asn<break/>c.1288Câ&gt;âT/p.Gln430*</td><td>c.389Câ&gt;âA/p.Thr130Asn<break/>c.1288Câ&gt;âT/p.Gln430*</td><td>c.458Â Tâ&gt;âC/p.Phe153Ser<break/>c.1355_1356del/p.Ala452Glyfs*52</td><td>c.2612Aâ&gt;âC/p.His871Pro<break/>c.1810dupC/p.Arg604ProfsTer40</td></tr></tbody></table><table-wrap-foot><p>
<italic>NA</italic> not available</p></table-wrap-foot></table-wrap>
</p>
      <p>Cutaneous abnormalities have been reported in two other GPI anchor synthesis disorders. In patients with PIGA deficiency, dry scaling, ichthyosis-like and eczema-like lesions, pigmentation abnormalities, and linear plaque-like scales, including the feet, have been described [<xref ref-type="bibr" rid="CR11">11</xref>]. More consistent skin lesions have been reported in patients with PIGL deficiency or CHIME syndrome (coloboma, congenital heart defects, early onset migratory ichthyosiform dermatosis, mental retardation, and ear anomalies, including conductive hearing loss). A diffuse, erythematous, pruritic, often migratory rash at or shortly after birth (sometimes even erythroderma) was present in all described cases. Thereafter, the skin becomes increasingly ichthyotic; primarily at the flexural surfaces [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. GPI anchoring plays a role in skin cells, particularly in keratinocytes. An epidermal-specific defect of GPI anchor in Pig-a null mice results in Harlequin ichthyosis-like features [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. In these mice, there was an impaired processing of profilaggrin to filaggrin, accompanied by a decreased activity of protein phosphatase 2A involved in this processing. Proteasin, one of the enzymes involved in filaggrin synthesis, is a GPI-anchored protein, and in mice its deficiency leads to a phenotype comparable to matriptase deficiency, a cause of autosomal recessive ichthyosis with hypotrichosis [<xref ref-type="bibr" rid="CR15">15</xref>]. On the other hand, Tam et al. have shown that GPI-anchored proteins regulate transforming growth factor-beta signalling in human keratinocytes [<xref ref-type="bibr" rid="CR16">16</xref>].</p>
      <p>Platelet function has not been studied in GPI anchor disorders, probably because until now no patient showed a haematological phenotype. We studied it in our patient as part of the etiological work-up in unexplained psychomotor disability. A characteristic feature of PIGO deficiency (and of six other known GPI anchor synthesis defects, namely in PIGA, PIGV, PIGW, PGAP1, PGAP2 and PGAP3) is the increase of serum alkaline phosphatase (tissue nonspecific; liver/bone/kidney), while in PIGT deficiency serum alkaline phosphatase is decreased [<xref ref-type="bibr" rid="CR17">17</xref>] (reminiscent of hereditary hypophosphatasia). Alkaline phosphatase testing may be helpful in the etiological work-up of patients with (syndromic or non-syndromic) intellectual disability, and the finding of increased or decreased levels of this enzyme should prompt a search for a GPI anchor defect.</p>
      <p>Coagulation and platelets defects have been reported in different congenital disorders of glycosylation as important receptors and proteins for coagulation, platelet formation and function are regulated by glycosylation [<xref ref-type="bibr" rid="CR18">18</xref>â<xref ref-type="bibr" rid="CR25">25</xref>]. The importance of GPI-anchoring for platelet proteins is not well studied. It is known that GPI-anchored glycoproteins are absent or deficient in platelets from patients with paroxysmal nocturnal haemoglobinuria (PNH) [<xref ref-type="bibr" rid="CR26">26</xref>]. PNH is an acquired stem cell disorder due to somatic variants in <italic>PIGA</italic> and causes an abnormal susceptibility of erythrocytes to complement induced lysis, resulting in episodes of intravascular haemolysis, haemoglobinuria and both thromboembolic events and bleeding complications. Platelets from PNH cases showed platelet hyporeactivity using in vitro assays possibly due to chronic hyperstimulation in the circulation [<xref ref-type="bibr" rid="CR27">27</xref>]. Though functional platelet defects have not been reported in the other patients with <italic>PIGO</italic> variants, we detected a multi- agonist platelet defect in our patient as a subclinical phenotype. Further studies need to be undertaken to support these findings and compare them with PNH.</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec4">
          <title>Additional file</title>
          <p>
<media position="anchor" xlink:href="13023_2017_654_MOESM1_ESM.docx" id="MOESM1"><label>Additional file 1:</label><caption><p> Gene selection from WES data. (DOCX 105 kb)</p></caption></media>
</p>
        </sec>
      </app>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>CDG</term>
          <def>
            <p>Congenital disorder(s) of glycosylation</p>
          </def>
        </def-item>
        <def-item>
          <term>GPI</term>
          <def>
            <p>Glycosylphosphatidylinositol</p>
          </def>
        </def-item>
        <def-item>
          <term>PIGO</term>
          <def>
            <p>Phosphatidylinositol glycan anchor biosynthesis class O protein</p>
          </def>
        </def-item>
        <def-item>
          <term>PNH</term>
          <def>
            <p>Paroxysmal nocturnal hemoglobinuria</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Electronic supplementary material</bold>
        </p>
        <p>The online version of this article (doi:10.1186/s13023-017-0654-9) contains supplementary material, which is available to authorized users.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This study makes use of whole genome sequencing data and analysis approaches generated by the NIHR BioResource - Rare Disease BRIDGE Consortium. The NIHR BioResource - Rare Diseases is funded by the National Institute for Health Research of England (NIHR, <ext-link ext-link-type="uri" xlink:href="http://www.nihr.ac.uk/">www.nihr.ac.uk</ext-link>; award number RG65966).</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>KF is supported by the Fund for Scientific Research-Flanders (FWO-Vlaanderen, Belgium, G.0B17.13Â N] and by the Research Council of the University of Leuven (BOF KU Leuvenâ Belgium, OT/14/098].</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and material</title>
        <p>Not applicable.</p>
      </sec>
      <sec id="FPar3">
        <title>Authorsâ contributions</title>
        <p>MAM and JJ conceived and designed the study. Genetic data were generated by NIHR BioResource and ISi, and analyzed by ET and KF. MAM, JJ, GV, ISa, CVG, and KF wrote the paper. All authors reviewed the compiled manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written consent for publication was provided by the parents, whom we thank for the help.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>The Institutional Review Board of the University Hospital Gasthuisberg Leuven approved this study.</p>
      </sec>
      <sec id="FPar7">
        <title>Publisherâs Note</title>
        <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fujita</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kinoshita</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>GPI-anchor remodelling: potential functions of GPI-anchors in intracellular trafficking and membrane dynamics</article-title>
          <source>Biochim Biophys Acta</source>
          <year>1821</year>
          <volume>2012</volume>
          <fpage>1050</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kinoshita</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Biosynthesis and deficiencies of glycosylphosphatidylinositol</article-title>
          <source>Proc Jpn Acad Ser B</source>
          <year>2014</year>
          <volume>90</volume>
          <fpage>130</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="doi">10.2183/pjab.90.130</pub-id>
          <pub-id pub-id-type="pmid">24727937</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Freeze</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>Human genetic disorders involving glycosylphosphatidylinositol (GPI) anchors and glycosphingolipids</article-title>
          <source>J Inherit Metab Dis</source>
          <year>2015</year>
          <volume>38</volume>
          <fpage>171</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1007/s10545-014-9752-1</pub-id>
          <?supplied-pmid 25164783?>
          <pub-id pub-id-type="pmid">25164783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jaeken</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Hennet</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Matthijs</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Freeze</surname>
              <given-names>HH</given-names>
            </name>
          </person-group>
          <article-title>CDG nomenclature: time for a change!</article-title>
          <source>Biochim Biophys Acta</source>
          <year>2009</year>
          <volume>1792</volume>
          <fpage>825</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/j.bbadis.2009.08.005</pub-id>
          <?supplied-pmid 19765534?>
          <pub-id pub-id-type="pmid">19765534</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krawitz</surname>
              <given-names>PM</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in <italic>PIGO</italic>, a member of the GPI-anchor synthesis pathway, cause hyperphosphatasia with mental retardation</article-title>
          <source>Am J Hum Genet</source>
          <year>2012</year>
          <volume>91</volume>
          <fpage>146</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.05.004</pub-id>
          <?supplied-pmid 22683086?>
          <pub-id pub-id-type="pmid">22683086</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuki</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Takahashi</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Vitamin B6-responsive epilepsy due to inherited GPI deficiency</article-title>
          <source>Neurology</source>
          <year>2013</year>
          <volume>81</volume>
          <fpage>1467</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a8411a</pub-id>
          <?supplied-pmid 24049131?>
          <pub-id pub-id-type="pmid">24049131</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Osaka</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title><italic>PIGO</italic> mutations in intractable epilepsy and severe developmental delay with mild elevation of alkaline phosphatase levels</article-title>
          <source>Epilepsia</source>
          <year>2014</year>
          <volume>55</volume>
          <fpage>e13</fpage>
          <lpage>e17</lpage>
          <pub-id pub-id-type="doi">10.1111/epi.12508</pub-id>
          <?supplied-pmid 24417746?>
          <pub-id pub-id-type="pmid">24417746</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xue</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Clinical and genetic analysis of two Chinese infants with Mabry syndrome</article-title>
          <source>Brain Dev</source>
          <year>2016</year>
          <volume>38</volume>
          <fpage>807</fpage>
          <lpage>18</lpage>
          <pub-id pub-id-type="doi">10.1016/j.braindev.2016.04.008</pub-id>
          <?supplied-pmid 27177984?>
          <pub-id pub-id-type="pmid">27177984</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Salles</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Broos</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fontayne</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Development of a high-throughput ELISA assay for platelet function testing using platelet-rich plasma or whole blood</article-title>
          <source>Thromb Haemost</source>
          <year>2010</year>
          <volume>104</volume>
          <fpage>392</fpage>
          <lpage>401</lpage>
          <pub-id pub-id-type="doi">10.1160/TH09-07-0505</pub-id>
          <?supplied-pmid 20508902?>
          <pub-id pub-id-type="pmid">20508902</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westbury</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Turro</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Greene</surname>
              <given-names>D</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders</article-title>
          <source>Genome Med</source>
          <year>2015</year>
          <volume>7</volume>
          <fpage>36</fpage>
          <pub-id pub-id-type="doi">10.1186/s13073-015-0151-5</pub-id>
          <?supplied-pmid 25949529?>
          <pub-id pub-id-type="pmid">25949529</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Swoboda</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Margraf</surname>
              <given-names>RL</given-names>
            </name>
            <name>
              <surname>Carey</surname>
              <given-names>JC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a neurodegenerative X-linked epileptic encephalopathy with systemic iron overload</article-title>
          <source>Am J Med Genet A</source>
          <year>2014</year>
          <volume>164A</volume>
          <fpage>17</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.a.36189</pub-id>
          <?supplied-pmid 24259288?>
          <pub-id pub-id-type="pmid">24259288</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>BG</given-names>
            </name>
            <name>
              <surname>Hackmann</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>MA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome</article-title>
          <source>Am J Hum Genet</source>
          <year>2012</year>
          <volume>90</volume>
          <fpage>685</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.02.010</pub-id>
          <?supplied-pmid 22444671?>
          <pub-id pub-id-type="pmid">22444671</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tinschert</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Anton-Lamprecht</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Albrecht-Nebe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Audring</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Zunich neuroectodermal syndrome:migratory ichthyosiform dermatosis, coloboma and other abnormalities</article-title>
          <source>Pediatr Dermatol</source>
          <year>1996</year>
          <volume>13</volume>
          <fpage>363</fpage>
          <lpage>71</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1525-1470.1996.tb00702.x</pub-id>
          <?supplied-pmid 8893234?>
          <pub-id pub-id-type="pmid">8893234</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hara-Chikuma</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takeda</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Tarutani</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Epidermal-specific defect of GPI anchor in Pig-a null mice results in harlequin ichthyosis-like features</article-title>
          <source>J Invest Dermatol</source>
          <year>2004</year>
          <volume>123</volume>
          <fpage>464</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1111/j.0022-202X.2004.23227.x</pub-id>
          <?supplied-pmid 15304084?>
          <pub-id pub-id-type="pmid">15304084</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ovaere</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Lippens</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vandenabeele</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Declercq</surname>
              <given-names>W</given-names>
            </name>
          </person-group>
          <article-title>The emerging roles of serine protease cascades in the epidermis</article-title>
          <source>Trends Biochem Sci</source>
          <year>2009</year>
          <volume>34</volume>
          <fpage>453</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tibs.2009.08.001</pub-id>
          <?supplied-pmid 19726197?>
          <pub-id pub-id-type="pmid">19726197</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tam</surname>
              <given-names>BY</given-names>
            </name>
            <name>
              <surname>Finnson</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Philip</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Glycosylphosphatidylinositol-anchored proteins regulate transforming growth factor-beta signalling in human keratinocytes</article-title>
          <source>J Biol Chem</source>
          <year>2003</year>
          <volume>278</volume>
          <fpage>49610</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M308492200</pub-id>
          <?supplied-pmid 14504277?>
          <pub-id pub-id-type="pmid">14504277</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nakashima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kashii</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Murakami</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel compound heterozygous <italic>PIGT</italic> mutations caused multiple congenital anomalies-hypotonia-seizures syndrome 3</article-title>
          <source>Neurogenetics</source>
          <year>2014</year>
          <volume>15</volume>
          <fpage>193</fpage>
          <lpage>200</lpage>
          <pub-id pub-id-type="doi">10.1007/s10048-014-0408-y</pub-id>
          <?supplied-pmid 24906948?>
          <pub-id pub-id-type="pmid">24906948</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Van Geet</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jaeken</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Freson</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Congenital disorders of glycosylation type Ia and IIa are associated with different primary hemostatic complications</article-title>
          <source>J Inherit Metab Dis</source>
          <year>2001</year>
          <volume>24</volume>
          <fpage>477</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1023/A:1010581613821</pub-id>
          <?supplied-pmid 11596651?>
          <pub-id pub-id-type="pmid">11596651</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de la Morena-Barrio</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Di Michele</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lozano</surname>
              <given-names>ML</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients</article-title>
          <source>Thromb Res</source>
          <year>2014</year>
          <volume>133</volume>
          <fpage>412</fpage>
          <lpage>17</lpage>
          <pub-id pub-id-type="doi">10.1016/j.thromres.2013.12.024</pub-id>
          <?supplied-pmid 24388574?>
          <pub-id pub-id-type="pmid">24388574</pub-id>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Noelle</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Knuepfer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Pulzer</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Unusual presentation of congenital disorder of glycosylation type 1a: congenital persistent thrombocytopenia, hypertrophic cardiomyopathy and hydrops-like aspect due to marked peripheral oedema</article-title>
          <source>Eur J Pediatr</source>
          <year>2005</year>
          <volume>164</volume>
          <fpage>223</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1007/s00431-004-1611-x</pub-id>
          <?supplied-pmid 15645285?>
          <pub-id pub-id-type="pmid">15645285</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jones</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Denecke</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>StrÃ¤ter</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A novel type of macrothrombocytopenia associated with a defect in Î±2,3-sialylation</article-title>
          <source>Am J Pathol</source>
          <year>2011</year>
          <volume>179</volume>
          <fpage>1969</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ajpath.2011.06.012</pub-id>
          <?supplied-pmid 21864493?>
          <pub-id pub-id-type="pmid">21864493</pub-id>
        </element-citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Jobe</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>X</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Platelet biogenesis and function require correct protein O-glycosylation</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2012</year>
          <volume>109</volume>
          <fpage>16143</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.1208253109</pub-id>
          <?supplied-pmid 22988088?>
          <pub-id pub-id-type="pmid">22988088</pub-id>
        </element-citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Badirou</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Kurdi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Legendre</surname>
              <given-names>P</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In vivo analysis of the role of O-glycosylations of von Willebrand factor</article-title>
          <source>PLoS One</source>
          <year>2012</year>
          <volume>7</volume>
          <fpage>e37508</fpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0037508</pub-id>
          <?supplied-pmid 22616016?>
          <pub-id pub-id-type="pmid">22616016</pub-id>
        </element-citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alexander</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Viney</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>16442</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.0607872103</pub-id>
          <?supplied-pmid 17062753?>
          <pub-id pub-id-type="pmid">17062753</pub-id>
        </element-citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>OâDonnell</surname>
              <given-names>SR</given-names>
            </name>
            <name>
              <surname>Kay</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Effects of endothelin receptor selective antagonists, BQ-123 and BQ-788, on IRL 1620 and endothelin 1 responses of airway and vascular preparations from rats</article-title>
          <source>Pulm Pharmacol</source>
          <year>1995</year>
          <volume>8</volume>
          <fpage>11</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1006/pulp.1995.1002</pub-id>
          <?supplied-pmid 8535094?>
          <pub-id pub-id-type="pmid">8535094</pub-id>
        </element-citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maciejewski</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Young</surname>
              <given-names>NS</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Sloand</surname>
              <given-names>EM</given-names>
            </name>
          </person-group>
          <article-title>Analysis of the expression of glycosylphosphatidylinositol anchored proteins on platelets from patients with paroxysmal nocturnal hemoglobinuria</article-title>
          <source>Thromb Res</source>
          <year>1996</year>
          <volume>83</volume>
          <fpage>433</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="doi">10.1016/0049-3848(96)00153-3</pub-id>
          <?supplied-pmid 8885138?>
          <pub-id pub-id-type="pmid">8885138</pub-id>
        </element-citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>GrÃ¼newald</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>GrÃ¼newald</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Schmid</surname>
            </name>
            <etal/>
          </person-group>
          <article-title>The platelet function defect of paroxysmal nocturnal hemoglobinuria</article-title>
          <source>Platelets</source>
          <year>2004</year>
          <volume>15</volume>
          <fpage>145</fpage>
          <lpage>54</lpage>
          <pub-id pub-id-type="doi">10.1080/09537105310001657110</pub-id>
          <?supplied-pmid 15203716?>
          <pub-id pub-id-type="pmid">15203716</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>